Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Xiaoer Xiaozhi Decoction is a traditional Chinese medicine (TCM) hospital-made preparation (院内制剂) developed by the Pediatric Department of Beijing Hepingli Hospital. It is specifically indicated for the treatment of simple obesity in children. The formula is designed based on TCM principles to strengthen the spleen, resolve phlegm, and eliminate dampness and blood stasis, addressing the underlying metabolic imbalances associated with pediatric weight gain. Clinical studies conducted at the hospital have demonstrated its efficacy in reducing body weight, body mass index (BMI), and waist circumference, while also improving lipid profiles (reducing cholesterol and triglycerides) in pediatric patients. As a hospital preparation, its use is typically localized to the developing institution and its affiliated medical networks.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on xiaoer xiaozhi decoction.